SynthesisFrontiers in oncology2026
Global hotspots and trends in the application of neoadjuvant therapy for gastric cancer: a bibliometric analysis.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Neoadjuvant therapy (NAT) is increasingly being applied in gastric cancer (GC) and is recognized by international guidelines. This study aims to analyze the current status, hotspots, and research trends of NAT in GC through bibliometrics. Methods: Relevant publications were collected from Web of Science (SCI-Expanded) and PubMed. We utilized Citespace to analyze countries, institutions, and keywords, and employed Vosviewer to examine authors and their co-cited authors, as well as journals and their co-cited journals. Results: The analysis encompassed 2666 documents. The overall number of publications showed an upward trend. The top-producing countries, institutions, authors, and journals in this field were: The People's Republic of China and Chinese Academy of Medical Sciences - Peking Union Medical College, Huang, Changming, and Annals of Surgical Oncology. The most frequently cited author and journal are Al-batran and the Journal of Clinical Oncology, respectively. Key research areas in this field include: diverse NAT strategies; open-label trials and survival outcomes; and technology empowerment. Potential future research trends encompass: deep learning applications; immune checkpoint inhibitors; nivolumab; and immunotherapy. Conclusion: We used bibliometrics to conduct a visual analysis of the application of NAT in GC. Research hotspots include diverse NAT strategies, open-label trials and survival outcomes, and technology empowerment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.